Although there was variation in price between select multiple sclerosis drugs, in all cases the U.S. price per dose was higher than the average of the 11 other countries in this analysis. Avonex, was over 1,400 U.S. dollars more expensive in the U.S. compared to the non-U.S. average price.
Price comparison U.S. vs. international per dose for select multiple sclerosis drugs in 2018*
(in U.S. dollars)
* Based on price data for 2018, collected from recognized price sources. Countries included in analysis: United States, United Kingdom, Japan, Canada, Australia, Portugal, France, Netherlands, Germany, Denmark, Sweden, Switzerland. Comparison is with U.S. drug prices under Medicare Part D. Information on types of Multiple Sclerosis medication provided by National Multiple Sclerosis Society.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
US House of Representatives (Committee on Ways and Means). (September 23, 2019). Price comparison U.S. vs. international per dose for select multiple sclerosis drugs in 2018* (in U.S. dollars) [Graph]. In Statista. Retrieved November 19, 2024, from https://www.statista.com/statistics/1134367/ms-drug-prices-international-average-vs-us/
US House of Representatives (Committee on Ways and Means). "Price comparison U.S. vs. international per dose for select multiple sclerosis drugs in 2018* (in U.S. dollars)." Chart. September 23, 2019. Statista. Accessed November 19, 2024. https://www.statista.com/statistics/1134367/ms-drug-prices-international-average-vs-us/
US House of Representatives (Committee on Ways and Means). (2019). Price comparison U.S. vs. international per dose for select multiple sclerosis drugs in 2018* (in U.S. dollars). Statista. Statista Inc.. Accessed: November 19, 2024. https://www.statista.com/statistics/1134367/ms-drug-prices-international-average-vs-us/
US House of Representatives (Committee on Ways and Means). "Price Comparison U.S. Vs. International per Dose for Select Multiple Sclerosis Drugs in 2018* (in U.S. Dollars)." Statista, Statista Inc., 23 Sep 2019, https://www.statista.com/statistics/1134367/ms-drug-prices-international-average-vs-us/
US House of Representatives (Committee on Ways and Means), Price comparison U.S. vs. international per dose for select multiple sclerosis drugs in 2018* (in U.S. dollars) Statista, https://www.statista.com/statistics/1134367/ms-drug-prices-international-average-vs-us/ (last visited November 19, 2024)
Price comparison U.S. vs. international per dose for select multiple sclerosis drugs in 2018* (in U.S. dollars) [Graph], US House of Representatives (Committee on Ways and Means), September 23, 2019. [Online]. Available: https://www.statista.com/statistics/1134367/ms-drug-prices-international-average-vs-us/
